Value investing message boards image Log on |  Join ($$) Stock market forums image VF "How To" Guide        Welcome, guest! Learn about guest access                       
ValueForum.com Home
• Related Discussion Forum Messages
As a ValueForum member, this section would contain LGND message board posts where the ticker symbol LGND has been mentioned by ValueForum members in posts. Learn more about guest access, and benefits of membership -- we hope you will consider joining ValueForum or trying out our service with a 24 hour trial pass.

• Latest LGND SEC Filings

Filings Format Description Filing Date File/Film Number
8-K  Documents Current report, items 2.02 and 9.01
Acc-no: 0000886163-18-000022 (34 Act)  Size: 367 KB
2018-02-21 001-33093
18628422
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0000886163-18-000019 Size: 7 KB
2018-02-16
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0000886163-18-000018 Size: 7 KB
2018-02-16
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0000886163-18-000017 Size: 9 KB
2018-02-16
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0000886163-18-000016 Size: 6 KB
2018-02-16
SC 13G/A  Documents [Amend] Statement of acquisition of beneficial ownership by individuals
Acc-no: 0001144204-18-007810 (34 Act)  Size: 54 KB
2018-02-13 005-43329
18602205
SC 13G/A  Documents [Amend] Statement of acquisition of beneficial ownership by individuals
Acc-no: 0001104659-18-008755 (34 Act)  Size: 58 KB
2018-02-13 005-43329
18599265
SC 13G/A  Documents [Amend] Statement of acquisition of beneficial ownership by individuals
Acc-no: 0000932471-18-003656 (34 Act)  Size: 45 KB
2018-02-09 005-43329
18589055
8-K  Documents Current report, item 5.02
Acc-no: 0000886163-18-000011 (34 Act)  Size: 33 KB
2018-01-29 001-33093
18556690
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0000886163-18-000009 Size: 4 KB
2018-01-26
More LGND SEC Filings


Related news from
Fri, 23 Feb 2018
13:06:19 +0000
See what the IHS Markit Score report has to say about Ligand Pharmaceuticals Inc.
Ligand Pharmaceuticals Inc NASDAQ NMS:LGND
Thu, 22 Feb 2018
15:17:03 +0000
Ligand (LGND) Q4 Earnings & Revenues Top, 2018 View Solid
Ligand's (LGND) earnings and revenues beat estimates. The top line also rises year over year owing to higher royalty benefits. The company provides a strong 2018 guidance.
Wed, 21 Feb 2018
22:31:00 +0000
Ligand reports 4Q loss
The San Diego-based company said it had a loss of 33 cents per share. Earnings, adjusted for one-time gains and costs, were $1.31 per share. The drugmaker posted revenue of $50.5 million in the period, ...
Wed, 21 Feb 2018
21:01:00 +0000
Ligand Reports Fourth Quarter and Full Year 2017 Financial Results
Ligand Pharmaceuticals Incorporated today reported financial results for the three and 12 months ended December 31, 2017, and provided an operating forecast and program updates.
Wed, 21 Feb 2018
17:15:00 +0000
Ligand Pharmaceuticals Incorporated to Host Earnings Call
NEW YORK, NY / ACCESSWIRE / February 21, 2018 / Ligand Pharmaceuticals Incorporated (NASDAQ: LGND ) will be discussing their earnings results in their Q4 Earnings Call to be held on February 21, 2018, ...
Wed, 21 Feb 2018
15:40:06 +0000
Ligand Pharmaceuticals Q4 Earnings Preview
On Wednesday, Ligand Pharmaceuticals (NASDAQ: LGND ) will release its latest earnings report. Here is Benzinga's outlook for the company. Earnings and Revenue Based on Ligand management projections, analysts ...
Tue, 20 Feb 2018
14:02:06 +0000
Promacta and Jakavi May Boost Novartis’s Oncology Segment Revenues
Novartis: What Are the Major Growth Drivers for 2018? Novartis’s (NVS) Promacta reported sales if $255 million in 4Q17, which is a year-over-year (or YoY) rise of 43.0% on a constant currency basis. On January 4, 2018, Novartis announced that the FDA granted breakthrough therapy designation to the combination of Promacta and immunosuppressive therapy.
Mon, 19 Feb 2018
15:10:03 +0000
What's in Store for Ligand (LGND) This Earnings Season?
Ligand's (LGND) Captisol formulation technology aids the company to form partnerships with several leading healthcare companies. This in turn might drive the stock in Q4.
Mon, 12 Feb 2018
13:20:00 +0000
Investor Expectations to Drive Momentum within A. O. Smith, Jacobs Engineering Group, Ligand Pharmaceuticals, National CineMedia, American Renal Associates, and Acco Brands — Discovering Underlying Factors of Influence
NEW YORK, Feb. 12, 2018-- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of A. ...
Mon, 05 Feb 2018
21:01:00 +0000
Ligand to Report Fourth Quarter and Full Year 2017 Results on February 21st
Ligand Pharmaceuticals Incorporated announced today plans to report fourth quarter and full year 2017 financial results on February 21, 2018. Ligand’s CEO John Higgins, President and COO Matt Foehr and Executive Vice President and CFO Matt Korenberg will host the conference call.
Mon, 29 Jan 2018
12:02:00 +0000
3 Biotech Stocks to Buy for 2018
This could be a big year for biotech, and here are three names that could make some big moves.
Tue, 23 Jan 2018
20:28:25 +0000
10 Risky (But Rewarding) Small-Cap Stocks to Buy Now
With the market up 22% up over the course of the past year, led by giants like Amazon.com, Inc. (NASDAQ:AMZN) and Facebook, Inc. (NASDAQ:FB), investors might fear that a pullback is just around the corner. If you’d rather not start that search one your own, here’s a look at ten small-cap stocks to buy. As with all risky investments, these small-cap stocks to buy have to be kept on a short leash and require plenty of monitoring.
Mon, 22 Jan 2018
14:00:00 +0000
Ligand Enters into Worldwide OmniAb® Platform License Agreement with Ferring Pharmaceuticals
Ligand Pharmaceuticals Incorporated announces it has entered into a worldwide OmniAb platform license agreement with Ferring Pharmaceuticals. Under the license, Ferring will be able to use the full OmniAb platform including OmniRat®, OmniMouse®, OmniFlic® and OmniChicken™ to discover fully human mono- and bispecific antibodies.
Fri, 19 Jan 2018
18:52:01 +0000
10 Stocks to Buy Instead of Bitcoin
Good stocks that are on a solid growth path will help you remain cool while crypto investors are watching every uptick and downtick. Caterpillar Inc (NYSE: CAT) is the 800-pound gorilla of the heavy-duty machinery business. For the past decade, CAT stock has been floundering because there wasn’t much growth, so there was no demand for equipment.
Thu, 18 Jan 2018
21:01:00 +0000
Ligand Establishes Program to Develop Captisol-Enabled, Next-Generation Contrast Agents for Diagnostic Imaging
Ligand Pharmaceuticals Incorporated announces initiation of a program to develop contrast agents with reduced renal toxicity. Contrast agents are injectable solutions used during diagnostic imaging procedures.
Wed, 17 Jan 2018
20:14:54 +0000
5 Big Biotech Stocks To Buy In 2018
While most investors tend to think of biotech stocks as pure lotto tickets, the reality is the sector is much more nuanced than that. Sure, there are bootstrapped, clinical-stage biotech stocks with only one potential drug in their arsenal.



"ValueForum is an active, private, online discussion community for stock & bond market investing. In discussion forums divided into finely grained topics, you will find sophisticated investors trading tips, research, and due diligence on value stocks, income investments, forex, market news, and more. Join in - trade ideas, strategies, current news, via our unique message bulletin boards, stock ratings system, and other online tools specifically geared toward our community."

Random member testimonial: "I joined almost three years ago and have never been sorry. The search features here are terrific." more testimonials »

Email / About | Privacy | Terms of Use | How To / FAQ | Msg Ticker | VF Home | My.vf | BDCs.vf | Energy.vf | REITs.vf | TA.vf
 
Nothing in ValueForum.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by ValueForum.com. ©2003 - 2018, Powered in part by Ticker TechnologiesContact Us

Stock Market Investing Forum - Trading Tips & Research - Online Message Boards